Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

(S,R,S)-AHPC-PEG5-COOH

Copy Product Info
😃Good
Catalog No. T18872Cas No. 2172820-14-1
Alias VHL Ligand-Linker Conjugates 16, VH032-PEG5-COOH, E3 Ligase Ligand-Linker Conjugates 58

(S,R,S)-AHPC-PEG5-COOH (VH032-PEG5-COOH) is a synthetic E3 ligase ligand-linker conjugate developed for PROTAC technology, comprising the (S,R,S)-AHPC-based VHL ligand and a 5-unit PEG linker [1].

(S,R,S)-AHPC-PEG5-COOH

(S,R,S)-AHPC-PEG5-COOH

Copy Product Info
😃Good
Catalog No. T18872Alias VHL Ligand-Linker Conjugates 16, VH032-PEG5-COOH, E3 Ligase Ligand-Linker Conjugates 58Cas No. 2172820-14-1
(S,R,S)-AHPC-PEG5-COOH (VH032-PEG5-COOH) is a synthetic E3 ligase ligand-linker conjugate developed for PROTAC technology, comprising the (S,R,S)-AHPC-based VHL ligand and a 5-unit PEG linker [1].
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$465 days5 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
(S,R,S)-AHPC-PEG5-COOH (VH032-PEG5-COOH) is a synthetic E3 ligase ligand-linker conjugate developed for PROTAC technology, comprising the (S,R,S)-AHPC-based VHL ligand and a 5-unit PEG linker [1].
SynonymsVHL Ligand-Linker Conjugates 16, VH032-PEG5-COOH, E3 Ligase Ligand-Linker Conjugates 58
Chemical Properties
Molecular Weight750.9
FormulaC36H54N4O11S
Cas No.2172820-14-1
SmilesCc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCOCCOCCOCCOCCOCCC(O)=O)C(C)(C)C)cc1
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 100 mg/mL (133.17 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 5 mg/mL (6.66 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.3317 mL6.6587 mL13.3174 mL66.5868 mL
5 mM0.2663 mL1.3317 mL2.6635 mL13.3174 mL
10 mM0.1332 mL0.6659 mL1.3317 mL6.6587 mL
20 mM0.0666 mL0.3329 mL0.6659 mL3.3293 mL
50 mM0.0266 mL0.1332 mL0.2663 mL1.3317 mL
100 mM0.0133 mL0.0666 mL0.1332 mL0.6659 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy (S,R,S)-AHPC-PEG5-COOH | purchase (S,R,S)-AHPC-PEG5-COOH | (S,R,S)-AHPC-PEG5-COOH cost | order (S,R,S)-AHPC-PEG5-COOH | (S,R,S)-AHPC-PEG5-COOH chemical structure | (S,R,S)-AHPC-PEG5-COOH formula | (S,R,S)-AHPC-PEG5-COOH molecular weight